In fact, some peptide drugs (e.g., gonadotropin-releasing hormone analogs, somatostatin analogs) have been approved by the FDA to fight some cancer types (e.g., breast, prostate, lung neuroendocrine), as well as for cancer diagnosis [125]. Here, SST is linked to cancer.